Optimizing the Care of Mesenteric Ischemia

Session Description

There are a number of situations in which general and vascular surgeons must work cooperatively in the management of ischemic conditions involving the major abdominal viscera. This course will review the management of acute mesenteric ischemia, including both open thrombectomy and the role of catheter-based techniques. Techniques for assessment of bowel viability following revascularization will be reviewed. Complications of vascular interventions will be discussed, including ischemic colitis following open or endovascular repair of abdominal aortic aneurysm. The role of second-look laparotomy and the management of abdominal compartment syndrome in cases of mesenteric ischemia will be covered.

Moderator: Daniel G. Clair, MD, FACS, Columbia, SC

Co-Moderator: Carlos V. Brown, MD, FACS, Austin, TX


Diagnosis and Initial Medical Management
Ravi R. Rajani, MD, FACS, Atlanta, GA

Bowel Evaluation and Management
Andrew C. Bernard, MD, FACS, Lexington, KY

Role of Interventional Therapies for Revascularization
Zachary M. Arthurs, MD, San Antonio, TX

Role and Methods of Open Revascularization
Pedro G. Teixeira, MD, Austin, TX

Managing the Patient after Revascularization
Phillip J. Prest, DO, FACS, Irmo, SC

Mesenteric Venous Thrombosis: A Special Situation
Vincent L. Rowe, MD, FACS, Los Angeles, CA

Sponsored by the Advisory Council for Vascular Surgery

Target Audience

  • Practicing surgeons
  • Residents

Learning Objectives

  • Apply new knowledge and ideas to improve their surgical practice
  • Adapt concepts and quality measures in support of research advancements
  • Enhance the quality of patient care


For questions about the course, please contact elearning@facs.org.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Completion
  • 1.50 Self Assessment Credit
Course opens: 
Course expires: 

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.

(Download the full list of disclosures).

Faculty and Disclosures

Andrew C. Bernard, MD, FACS - Atox Bio: Fees, Research support: Consulting, clinical trial conduct
Carlos V. Brown MD, FACS - Nothing to Disclose
Daniel G. Clair, MD, FACS - Bard/BD: Data Safety Monitoring Board member; Cook Medical Inc: Speaker; Limflow: principal investigator; Medtronic: Advisory Board Member
Pedro G. Teixeira MD - Nothing to Disclose
Phillip J. Prest DO, FACOS, FACS - Nothing to Disclose
Ravi R. Rajani, MD, FACS - Cook Medical: Contracted Research: PI; Endologix: Contracted Research: PI; Humacyte, Inc: Contracted Research: PI; Penumbra: Contracted Research: PI; Terumo Aortic: Contracted Research: PI; ValenTx: Honoraria: Member of data safety and monitoring board
Vincent Lopez Rowe MD FACS - Nothing to Disclose
Zachary M. Arthurs, MD - Endologix: Consultant

Program Committee and Disclosures

CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure


David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure


Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure


Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure

Continuing Medical Education Credit Information


The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 1.5 credits meets the requirements for Self-Assessment.

American College of Surgeons and ACGME Logos

Note: Residents will receive a Certificate of Completion.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Certificate of Completion
  • 1.50 Self Assessment Credit
Please login or register to take this course.

This course is available as part of the Clinical Congress 2019 Webcast Packages